Suppr超能文献

1990年至2021年204个国家和地区屈光不正疾病负担:来自《2021年全球疾病负担》的系统分析

The burden of refraction disorders in 204 countries and territories from 1990 to 2021: A systematic analysis from the global burden of disease 2021.

作者信息

Shen Yunhan, Wang Linyan, Cui Yuxin, Mao Bangxun, Hooi Grace Loy Ming, Idowu Oluwatobi, Ye Juan, Zhu Tiansheng

机构信息

College of Mathematics and Computer Science, Zhejiang A & F University, Hangzhou, China.

Eye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China.

出版信息

Adv Ophthalmol Pract Res. 2024 Nov 6;5(2):79-87. doi: 10.1016/j.aopr.2024.11.001. eCollection 2025 May-Jun.

Abstract

BACKGROUND

Refraction disorders are common eye conditions that cause blurred vision and, if left uncorrected, remain a leading cause of moderate to severe visual impairment worldwide. Despite this, a comprehensive assessment of the associated burden is lacking. This study aims to describe and predict the burden and regional distribution of refraction disorders using data from the 2021 Global Burden of Disease (GBD) study.

METHODS

This study utilized data from the Global Burden of Disease (GBD) 2021 on refraction disorders from 1990 to 2021. We analyzed the prevalence and disability-adjusted life years (DALYs) of refraction disorders and calculated the corresponding average annual percentage changes (AAPCs) in different gender and age groups across 204 countries and territories and 21 geographical regions. We employed the Bayesian Age-Period-Cohort (BAPC) model to predict the future burden of refraction disorders.

RESULTS

From 1990 to 2021, the global age-standardized prevalence rate (ASPR) of refraction disorders decreased from 2053.56 (per 100000, 95% Uncertainty Interval [UI]: 1835.31 to 2275.80) to 1919.66 (per 100000, 95%UI: 1715.24 to 2135.28), with an average annual percentage change (AAPC) of -0.21% (95% Confidence Interval [CI]: -0.23% to -0.19%). The age-standardized DALY (Disability-Adjusted Life Years) rate also declined from 88.04 (per 100000, 95%UI: 62.19 to 125.15) to 79.11 (per 100000, 95%UI: 54.94 to 114.14) with an AAPC of -0.33% (95%CI: -0.36% to -0.31%). Refraction disorders remain a significant burden in regions with lower Socio-demographic Index (SDI), particularly in parts of South Asia and Western Sub-Saharan Africa. Older individuals and females are disproportionately affected. The age-standardized DALY rate is expected to decline steadily before stabilising at approximately 77.94 per 100000 by 2030.

CONCLUSIONS

From 1990 to 2021, the disease burden of refraction disorders showed a declining trend, but the decrease was not substantial. In some low-middle SDI regions, the burden remains high. Moreover, globally, women bear a higher burden than men. This study provides important information for the treatment and prevention of refraction disorders.

摘要

背景

屈光不正疾病是常见的眼部疾病,会导致视力模糊,若不加以矫正,仍是全球中重度视力损害的主要原因。尽管如此,目前仍缺乏对其相关负担的全面评估。本研究旨在利用2021年全球疾病负担(GBD)研究的数据,描述和预测屈光不正疾病的负担及其区域分布。

方法

本研究使用了全球疾病负担(GBD)2021中关于1990年至2021年屈光不正疾病的数据。我们分析了屈光不正疾病的患病率和伤残调整生命年(DALYs),并计算了204个国家和地区以及21个地理区域不同性别和年龄组的相应年均变化百分比(AAPCs)。我们采用贝叶斯年龄-时期-队列(BAPC)模型来预测屈光不正疾病未来的负担。

结果

1990年至2021年,全球屈光不正疾病的年龄标准化患病率(ASPR)从2053.56(每10万人,95%不确定区间[UI]:1835.31至2275.80)降至1919.66(每10万人,95%UI:1715.24至2135.28),年均变化百分比(AAPC)为-0.21%(95%置信区间[CI]:-0.23%至-0.19%)。年龄标准化的伤残调整生命年(DALY)率也从88.04(每10万人,95%UI:62.19至125.15)降至79.11(每10万人,95%UI:54.94至114.14),AAPC为-0.33%(95%CI:-0.36%至-0.31%)。在社会人口指数(SDI)较低的地区,屈光不正疾病仍是一项重大负担,特别是在南亚部分地区和撒哈拉以南非洲西部。老年人和女性受到的影响尤为严重。预计到2030年,年龄标准化的DALY率将在稳定在每10万人约77.94之前稳步下降。

结论

1990年至2021年,屈光不正疾病的疾病负担呈下降趋势,但降幅不大。在一些中低SDI地区,负担仍然很高。此外,在全球范围内,女性的负担高于男性。本研究为屈光不正疾病的治疗和预防提供了重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/140e/11930593/8f1d505190ec/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验